Recent Company News

• 09:55 PM ET Feb 19, 2026
  

  Nano Dimension holder Oramed reiterates dissatisfaction with management - 13D/A ($2.04, 0.00)

• 11:41 AM ET Feb 17, 2026
  

  StreetAccount Summary - U.S. Unusual Option Volume (^OPTIONS): VIX +1.9% to $21.00; S&P 500 (0.1%) to $6,829.65

• 12:45 PM ET Feb 06, 2026
  

  StreetAccount Activist Summary: Week of 2-Feb

• 06:42 PM ET Feb 02, 2026
  

  Nano Dimension adopts limited duration shareholder rights agreement ($1.88, 0.00)

• 01:48 PM ET Jan 30, 2026
  

  StreetAccount Activist Summary: Week of 26-Jan

• 04:48 PM ET Jan 29, 2026
  

  Nano Dimension holder Oramed Pharmaceuticals discloses 5.0% stake - 13D

• 11:54 AM ET Jan 29, 2026
  

  StreetAccount Summary - U.S. Unusual Option Volume (^OPTIONS): VIX +14.0% to $18.64; S&P 500 (1.1%) to $6,904.51

• 11:45 AM ET Jan 29, 2026
  

  StreetAccount Summary - US unusual volume traders

• 08:32 AM ET Jan 21, 2026
  

  Nano Dimension guides Q4 revenue $35.0M-35.5M vs prior guidance $31.5M-33.5M ($1.77, 0.00)

• 05:08 PM ET Nov 19, 2025
  

  Transcript Intelligence: Nano Dimension Q3 Earnings Guidance ($1.57, 0.00)